Valley of Death

Verdezyne exit confirmed

It was disheartening to hear about Verdezyne, which recently and abruptly closed down its operations a few days ago. This news recently followed our grim news about BioAmber filing for bankruptcy and Rennovia also exiting the market this year. I was attending Nova Institut’s Biomaterials conference in Cologne, Germany last week when I heard the rumor … Continue reading »